Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and clemastine

olmesartan has been researched along with clemastine in 1 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(clemastine)		Trials
(clemastine)		Recent Studies (post-2010) (clemastine)
84118555434710566

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)clemastine (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)4.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.099
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)3.086
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.02
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0084
Alpha-2A adrenergic receptorHomo sapiens (human)0.183
Cytochrome P450 2D6Homo sapiens (human)3
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.3951
D(2) dopamine receptorHomo sapiens (human)0.136
Alpha-2B adrenergic receptorHomo sapiens (human)0.311
Alpha-2C adrenergic receptorHomo sapiens (human)0.095
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.039
D(1A) dopamine receptorHomo sapiens (human)1.535
Sodium-dependent noradrenaline transporter Homo sapiens (human)3.086
Histamine H2 receptorHomo sapiens (human)0.37
Alpha-1D adrenergic receptorHomo sapiens (human)0.032
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.032
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.099
Cytochrome P450 2C19Homo sapiens (human)0.6
Histamine H1 receptorHomo sapiens (human)0.0004
D(3) dopamine receptorHomo sapiens (human)0.0073
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.036
5-hydroxytryptamine receptor 6Homo sapiens (human)0.077
5-hydroxytryptamine receptor 7Cavia porcellus (domestic guinea pig)4.9
Sodium-dependent dopamine transporter Homo sapiens (human)0.678
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.3951
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)0.3951
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1

Other Studies

1 other study(ies) available for olmesartan and clemastine

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012